desmopressin acetate

(redirected from DDAVP)
Also found in: Medical, Acronyms.

des·mo·pres·sin acetate

A synthetic analog of vasopressin used therapeutically as an antidiuretic and in the management of bleeding in individuals with some forms of hemophilia and von Willebrand disease.

[des(a)m(in)o-, lacking an amine group (des-, variant of de- + amino-) + (vaso)pressin.]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
References in periodicals archive ?
The administration of DDAVP, 20 [micro]g intranasally, also did not have any effect on urine parameters (Table 1).
Administration of the synthetic AVP homolog dDAVP is usually able to drastically decrease urine output in central DI patients, suggesting that AVP or dDAVP stimulation induces regulation of aquaporin proteins in renal medulla and cortex of DI patients.
Due to the risk of platelet dysfunction, postpartum hemorrhage, difficult uterine closure, and vascular fragility and in the setting of relatively benign side effect profiles, we elected to administer tranexamic acid and DDAVP [10,11].
DDAVP was discontinued, and the serum sodium normalized to 138 mEq/L 24 hours later.
For those with problematic nocturia, frequent urination during sleep, giving a dose of the DDAVP at bedtime can help with this as well.
[9] it could be shown that initial treatment with desmopressin (DDAVP, 0.3 [micro]g/kg) accompanied with thyroid hormone replacement significantly enhances platelet adhesiveness and plasma concentrations of factor VIII and vW-factor in ten patients with hypothyroidism [10].
Hoyer, "DDAVP (desmopressin) in the dental management of patients with mild or moderate hemophilia and von Willebrand's disease," Pediatric Dentistry, vol.
In AVWS associated with IgM-MGUS or IgG-MGUS, desmopressin (DDAVP) or vWF/factor VIII replacement can be used to both treat and prevent bleeding by transiently improving the bleeding time and increasing factor VIII and vWF levels [10].
Two micrograms of desmopressin (DDAVP) and two liters of electrolyte-free water were given intravenously to slow urine output and prevent rapid overcorrection of [S.sub.Na], respectively.
Desmopressin (DDAVP) is a synthetic replacement for vasopressin; it is a secretagogue of Von Willebrand factor.